La resonancia magnética en el estudio de lumbalgia. Un análisis de la oportunidad perdida para el diagnóstico de espondiloartritis axial
Palabras clave:
RMN, lumbalgia, espondiloartritis
Resumen
Objetivo: Describir las características de una población con lumbalgia estudiada por RM y analizar las características de los pacientes que cumplen criterios para ser derivados para estudio de EspA.Materiales y métodos: Estudio retrospectivo observacional, se incluyeron pacientes a quienes les fue solicitada RM para el estudio de lumbalgia. Se definió “población potencial para pesquisa de EspA” a los pacientes menores de 45 años con lumbalgia crónica. Análisis estadístico: se realizó el análisis descriptivo, test de Chi2 (categóricas) y test de Student o Mann Whitney (continuas). Análisis multivariado de regresión logística donde se consideró variable dependiente “Población potencial para pesquisa de EspA”.Citas
I. Rudwaleit M, van der Heijde D, Khan MA, Braun J, Sieper J. How to diagnose axial spondyloarthritis early. Ann Rheum Dis 2004;63:535-43.
II. Rudwaleit M, vanderHeijde D, Landewé R, Listing J, Akkoc N, Brandt J, et al. The development of Assessment of SpondyloArthritis International Society (ASAS)
classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009;68:777-83.
III. Rihn JA, Radcliff K, Norvell DC, Eastlack R, Phillips FM, Berland D, et al. Comparative Effectiveness of Treatments for Chronic Low Back Pain: A Multiple Treatment Comparison Analysis. Clin Spine Surg. 2016 Nov 9.
IV. Sieper J, Braun J. How important is early therapy in axial spondyloarthritis? Rheum Dis Clin North Am. 2012;38:635-42.
V. Zochling J, Brandt J, Braun J. The current concept of spondyloarthritis with special emphasis on undifferentiated spondyloarthritis. Rheumatology (oxford). 2005;44:14883-91.
VI. Sieper J, Rudwaleit M, Baraliakos X, Brandt J, Braun J, Burgos-vargas R, et al. The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis. 2009 Jun;68 Suppl 2:ii1-44.
VII. Dougados M, Baeten D. Spondyloarthritis. Lancet. 2011;377:2127-37.
VIII. Rudwaleit M, Jurik Ag, Hermann K-gA, Landewe R, van der Heijde D, Baraliakos X, et al. Defining active sacroileitis on magnetic resonance imaging (MRI) for
classification of axial spondyloarthritis: A consensual approach by the ASAS/oMERACT MRI group. Ann Rheum Dis. 2009;68:1520-7.
IX. Rillo OL, Papasidero SB. Lumbalgia. En: Reumatología/José Maldonado Cocco y gustavo Citera. 1ed. Ed Azurras. 2010.
X. Dincer u, Cakar E, Kiralp MZ, Dursun H. Diagnosis delay in patients with ankylosing spondylitis: posible reasons and proposals for new diagnostic criteria. Clin Rheumatol. 2008 Apr;27(4):457-62.
XI. Seo MR, Baek HL, Yoon HH, Ryu HJ, Choi HJ, Baek HJ, et al. Delayed diagnosis is linked to worse outcomes and un- favourable treatment responses in patients with axial spondyloarthritis. Clin Rheumatol. 2014 Sep 5.
XII. Buschiazzo E, Maldonado-Cocco JA, Arturi P, Citera G, Berman A, Nitsche A, et al. Epidemiology of spondyloarthritis in Argentina. Am J Med Sci. 2011 Apr;341(4):289-92.
XIII. Sieper J, Rudwaleit M. Early referral recommendations for ankylosing spondylitis (including pre-radiographic and radiographic forms) in primary care. Ann Rheum Dis. 2005 May;64(5):659-63.
XIV. García Salinas R, Arturi P, Giacomone D, Girard Bosch P, Martire v, Magri S. et al. Estrategia para la derivación oportuna: experiencia en un centro de referencia en reumatología. Rev Arg Reumatol. 2015;26(2):15-18.
XV. Schneeberger EE, Citera g, Buschiazzo E, Cayetti A, Zamora N, Sommerflek FA. et al. Impact of an awareness campaign for the detection of axial spondyloarthritis in patients with inflammatory back pain. J Rheumatol Arthritic Dis 2(1):1-6.
XVI. Van Hoeven L, vergouwe Y, Koes BW, Hazes JM, Weel AE. Study protocol for a cluster randomized controlled trial to evaluate a referral strategy for axial spondyloarthritis in young primary care patients with chronic low back pain; an impact study. BMC Musculoskelet Disord. 2016 Jul 12;17:278.
XVII. Van den Berg R, de Hooge M, Rudwaleit M, Sieper J, van gaalen F, Reijnierse M, et al. ASAS modification of the Berlin algorithm for diagnosing axial spondyloarthritis: results from the SPondyloArthritis Caught Early (SPACE)-cohort and from the Assessment of SpondyloArthritis international Society (ASAS)-cohort. Ann Rheum Dis. 2013 oct;72(10):1646-53.
XVIII. Benegas M, Muñoz-gomariz E, Font P, Burgos-vargas R, Chaves J, Palleiro D, et al. Comparison of the clinical expression of patients with ankylosing spondylitis from Europe and Latin America. J Rheumatol. 2012 Dec;39(12):2315-20.
XIX. Colombres F, Berman A, Berman H, Spindler A, Spinder W Citera g. Antígeno leucocitario humano (HLA) B27 y otras variantes alélicas del locus B en pacientes con espondiloartritis temprana en Argentina. Rev Arg Reumatol. 2014;(25).
XX. Mandl P, Navarro-Compán v, Terslev L, Aegerter P, van der Heijde D, D'Agostino MA, et al. EuLAR recommendations for the use of imaging in the
diagnosis and management of spondyloarthritis in clinical practice. Ann Rheum Dis. 2015 Jul;74(7):1327-39.
XXI. Hermann K, Baraliakos X, van der Heijde D, Jurik Ag, Landewé R, Marzo-ortega H, et al. Descriptions of spinal MRI lesions and de nition of a positive MRI of the
spine in axial spondyloarthritis: a consensual approach by the ASAS/oMERACT MRI study group. Ann Rheum Dis 2012;71:1278-1288.
XXII. Rudwaleit M, Haibel H, Baraliakos X, Listing J, MärkerHermann E, Zeidler H, et al. The early disease stage in axial spondylarthritis: results from the german
Spondyloarthritis Inception Cohort. Arthritis Rheum 2009;60(3):717-27.
XXIII. Kiltz u, Baraliakos X, Karakostas P, Igelmann M, Kalthoff L, Klink C, et al. Do patients with non-radiographic axial spondylarthritis differ from patients with ankylosing spondylitis? Arthritis Care Res 2012;64(9):1415-22.
XXIV. Baraliakos X, Brandt J, Listing J, Haibel H, Sörensen H, Rudwaleit M, et al. outcome of patients with active ankylosing spondylitis after two years of therapy with etanercept: clinical and magnetic resonance imaging data. Arthritis Rheum. 2005 Dec 15;53(6):856-63.
XXV. Rudwaleit M, Baraliakos X, Listing J, Brandt J, Sieper J, Braun J, et al. Magnetic resonance imaging of the spine and the sacroiliac joints in ankylosing spondylitis and undifferentiated spondyloarthritis during treatment with etanercept. Ann Rheum Dis. 2005 Sep;64(9):1305-10.
XXVI. Braun J, Baraliakos X, Hermann Kg, van der Heijde D, Inman RD, Deodhar AA, et al. golimumab reduces spinal inflammation in ankylosing spondylitis: MRI results of the randomised, placebo- controlled goRAISE study. Ann Rheum Dis. 2012 Jun;71(6):878-84.
XXVII. Smolen JS, Braun J, Dougados M, Emery P, Fitzgerald o, Helliwell P, et al. Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force. Ann Rheum Dis. 2014 Jan;73(1):6-16.
XXVIII. Van der Heijde D, Ramiro S, Landewé R, Baraliakos X, van den Bosch F, Sepriano A, et al. 2016 update of the ASAS-EuLAR management recommendations for axial spondyloarthritis. Ann Rheum Dis. 2017 Jan 13.
II. Rudwaleit M, vanderHeijde D, Landewé R, Listing J, Akkoc N, Brandt J, et al. The development of Assessment of SpondyloArthritis International Society (ASAS)
classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009;68:777-83.
III. Rihn JA, Radcliff K, Norvell DC, Eastlack R, Phillips FM, Berland D, et al. Comparative Effectiveness of Treatments for Chronic Low Back Pain: A Multiple Treatment Comparison Analysis. Clin Spine Surg. 2016 Nov 9.
IV. Sieper J, Braun J. How important is early therapy in axial spondyloarthritis? Rheum Dis Clin North Am. 2012;38:635-42.
V. Zochling J, Brandt J, Braun J. The current concept of spondyloarthritis with special emphasis on undifferentiated spondyloarthritis. Rheumatology (oxford). 2005;44:14883-91.
VI. Sieper J, Rudwaleit M, Baraliakos X, Brandt J, Braun J, Burgos-vargas R, et al. The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis. 2009 Jun;68 Suppl 2:ii1-44.
VII. Dougados M, Baeten D. Spondyloarthritis. Lancet. 2011;377:2127-37.
VIII. Rudwaleit M, Jurik Ag, Hermann K-gA, Landewe R, van der Heijde D, Baraliakos X, et al. Defining active sacroileitis on magnetic resonance imaging (MRI) for
classification of axial spondyloarthritis: A consensual approach by the ASAS/oMERACT MRI group. Ann Rheum Dis. 2009;68:1520-7.
IX. Rillo OL, Papasidero SB. Lumbalgia. En: Reumatología/José Maldonado Cocco y gustavo Citera. 1ed. Ed Azurras. 2010.
X. Dincer u, Cakar E, Kiralp MZ, Dursun H. Diagnosis delay in patients with ankylosing spondylitis: posible reasons and proposals for new diagnostic criteria. Clin Rheumatol. 2008 Apr;27(4):457-62.
XI. Seo MR, Baek HL, Yoon HH, Ryu HJ, Choi HJ, Baek HJ, et al. Delayed diagnosis is linked to worse outcomes and un- favourable treatment responses in patients with axial spondyloarthritis. Clin Rheumatol. 2014 Sep 5.
XII. Buschiazzo E, Maldonado-Cocco JA, Arturi P, Citera G, Berman A, Nitsche A, et al. Epidemiology of spondyloarthritis in Argentina. Am J Med Sci. 2011 Apr;341(4):289-92.
XIII. Sieper J, Rudwaleit M. Early referral recommendations for ankylosing spondylitis (including pre-radiographic and radiographic forms) in primary care. Ann Rheum Dis. 2005 May;64(5):659-63.
XIV. García Salinas R, Arturi P, Giacomone D, Girard Bosch P, Martire v, Magri S. et al. Estrategia para la derivación oportuna: experiencia en un centro de referencia en reumatología. Rev Arg Reumatol. 2015;26(2):15-18.
XV. Schneeberger EE, Citera g, Buschiazzo E, Cayetti A, Zamora N, Sommerflek FA. et al. Impact of an awareness campaign for the detection of axial spondyloarthritis in patients with inflammatory back pain. J Rheumatol Arthritic Dis 2(1):1-6.
XVI. Van Hoeven L, vergouwe Y, Koes BW, Hazes JM, Weel AE. Study protocol for a cluster randomized controlled trial to evaluate a referral strategy for axial spondyloarthritis in young primary care patients with chronic low back pain; an impact study. BMC Musculoskelet Disord. 2016 Jul 12;17:278.
XVII. Van den Berg R, de Hooge M, Rudwaleit M, Sieper J, van gaalen F, Reijnierse M, et al. ASAS modification of the Berlin algorithm for diagnosing axial spondyloarthritis: results from the SPondyloArthritis Caught Early (SPACE)-cohort and from the Assessment of SpondyloArthritis international Society (ASAS)-cohort. Ann Rheum Dis. 2013 oct;72(10):1646-53.
XVIII. Benegas M, Muñoz-gomariz E, Font P, Burgos-vargas R, Chaves J, Palleiro D, et al. Comparison of the clinical expression of patients with ankylosing spondylitis from Europe and Latin America. J Rheumatol. 2012 Dec;39(12):2315-20.
XIX. Colombres F, Berman A, Berman H, Spindler A, Spinder W Citera g. Antígeno leucocitario humano (HLA) B27 y otras variantes alélicas del locus B en pacientes con espondiloartritis temprana en Argentina. Rev Arg Reumatol. 2014;(25).
XX. Mandl P, Navarro-Compán v, Terslev L, Aegerter P, van der Heijde D, D'Agostino MA, et al. EuLAR recommendations for the use of imaging in the
diagnosis and management of spondyloarthritis in clinical practice. Ann Rheum Dis. 2015 Jul;74(7):1327-39.
XXI. Hermann K, Baraliakos X, van der Heijde D, Jurik Ag, Landewé R, Marzo-ortega H, et al. Descriptions of spinal MRI lesions and de nition of a positive MRI of the
spine in axial spondyloarthritis: a consensual approach by the ASAS/oMERACT MRI study group. Ann Rheum Dis 2012;71:1278-1288.
XXII. Rudwaleit M, Haibel H, Baraliakos X, Listing J, MärkerHermann E, Zeidler H, et al. The early disease stage in axial spondylarthritis: results from the german
Spondyloarthritis Inception Cohort. Arthritis Rheum 2009;60(3):717-27.
XXIII. Kiltz u, Baraliakos X, Karakostas P, Igelmann M, Kalthoff L, Klink C, et al. Do patients with non-radiographic axial spondylarthritis differ from patients with ankylosing spondylitis? Arthritis Care Res 2012;64(9):1415-22.
XXIV. Baraliakos X, Brandt J, Listing J, Haibel H, Sörensen H, Rudwaleit M, et al. outcome of patients with active ankylosing spondylitis after two years of therapy with etanercept: clinical and magnetic resonance imaging data. Arthritis Rheum. 2005 Dec 15;53(6):856-63.
XXV. Rudwaleit M, Baraliakos X, Listing J, Brandt J, Sieper J, Braun J, et al. Magnetic resonance imaging of the spine and the sacroiliac joints in ankylosing spondylitis and undifferentiated spondyloarthritis during treatment with etanercept. Ann Rheum Dis. 2005 Sep;64(9):1305-10.
XXVI. Braun J, Baraliakos X, Hermann Kg, van der Heijde D, Inman RD, Deodhar AA, et al. golimumab reduces spinal inflammation in ankylosing spondylitis: MRI results of the randomised, placebo- controlled goRAISE study. Ann Rheum Dis. 2012 Jun;71(6):878-84.
XXVII. Smolen JS, Braun J, Dougados M, Emery P, Fitzgerald o, Helliwell P, et al. Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force. Ann Rheum Dis. 2014 Jan;73(1):6-16.
XXVIII. Van der Heijde D, Ramiro S, Landewé R, Baraliakos X, van den Bosch F, Sepriano A, et al. 2016 update of the ASAS-EuLAR management recommendations for axial spondyloarthritis. Ann Rheum Dis. 2017 Jan 13.
Publicado
2015-09-01
Cómo citar
1.
García Salinas R. La resonancia magnética en el estudio de lumbalgia. Un análisis de la oportunidad perdida para el diagnóstico de espondiloartritis axial. Rev. Argent. Reumatol. [Internet]. 1 de septiembre de 2015 [citado 1 de diciembre de 2024];26(3):15 -19. Disponible en: https://ojs.reumatologia.org.ar/index.php/revistaSAR/article/view/636
Sección
Artículo Original
Derechos de autor 2015 A nombre de los autores. Derechos de reproducción: Sociedad Argentina de Reumatología
Esta obra está bajo licencia internacional Creative Commons Reconocimiento-NoComercial-SinObrasDerivadas 4.0.
